Who we are

SanaClis was founded in 2000 by seasoned industry experts all of whom have had executive level positions in leading pharma companies and large global CROs. SanaClis is a full-service European CRO offering a comprehensive range of services for clinical trials.

SanaClis has experience of successfully delivering studies for various sized sponsors, starting from virtual biotechs through to top 10 pharma companies. Every project is a priority for the SanaClis team, irrespective size or scope.
We believe that every company and professional deserves to feel that they are getting the best possible service, responsiveness and dedication that we routinely provide to our existing clients.

In additional to being a full service CRO, SanaClis is one of the very few service providers who has in-house logistics capabilities. This includes QP services, customs brokerage, warehousing and distribution, and sourcing of clinical trial materials, comparators and rescue medication.

Our awards

  • 2015: CRO Leadership Award in the category of Reliability
    2015-2017: Excellence in Drug Development - Europe & Best for Clinical Trials
  • 2013-2017: Certified with the AA rating 'High creditworthiness' by Bisnode rating agency
  • 2015: Nice Insight's survey of Top Ten lists of Clinical Research Organizations (CROs), based on customer perceptions of Quality.
  • 2016: Best Drug Development CRO 2016 – Europe & Award for Excellence in Clinical Trial Monitoring
  • 2016: Healthcare & Life Sciences Awards 2016 Winner - Most Outstanding in Drug Development Services
  • 2017: Health Tech & Pharma Innovation Awards 2016 - Software Innovation category
  • 2017: Healthcare & Life Sciences Awards - “Best in Contract Research Services”
  • 2017: Global Excellence Awards Most Innovative Contract Research & Clinical Studies Firm
  • 2017: Best Drug Development CRO 2017 & Award for Excellence in Clinical Trial Monitoring - Europe
Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.